← Back to Search

Mobile Health Program

Mobile Health Program for Mental Illness

N/A
Recruiting
Led By Dror Ben Zeev, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Chart diagnosis of a serious mental illness (i.e., schizophrenia, schizoaffective disorder, bipolar disorder, major depressive disorder)
18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if using a digital training platform can help improve the effectiveness of a mental health system called FOCUS in people with serious mental illness. Participants will use a smartphone app called FOCUS

Who is the study for?
This trial is for English-speaking adults (18+) with a serious mental illness like schizophrenia, schizoaffective disorder, bipolar disorder, or major depressive disorder. Participants must have access to a smartphone that supports the FOCUS app.
What is being tested?
The study tests if clinicians trained via a digital platform can effectively use the FOCUS mobile health system to help people with serious mental illnesses. It checks if patients achieve outcomes similar to past studies when using this tech-assisted method.
What are the potential side effects?
Since this trial involves a mobile application and coaching rather than medication, traditional side effects are not applicable. However, participants may experience discomfort or stress related to technology use or discussing their condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a serious mental illness.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in auditory verbal hallucinations
Change in depressive symptoms
Change in perceived quality of life
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: FOCUS participantsExperimental Treatment1 Intervention
FOCUS is a smartphone application system designed to improve illness self-management and facilitate recovery in individuals with serious mental illness. It delivers both system initiated (i.e. pre-programmed) and patient initiated (i.e. on demand) real-time assessment to individuals in their own environment.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,817 Previous Clinical Trials
1,914,143 Total Patients Enrolled
7 Trials studying Schizophrenia
1,367 Patients Enrolled for Schizophrenia
Patient-Centered Outcomes Research InstituteOTHER
574 Previous Clinical Trials
27,078,719 Total Patients Enrolled
5 Trials studying Schizophrenia
86,316 Patients Enrolled for Schizophrenia
Dror Ben Zeev, PhDPrincipal InvestigatorUniversity of Washington
~107 spots leftby Nov 2025